Burlibact T 1000mg/125mg Injection
Marketer
Unibiotech Formulations
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Burlibact T 1000mg/125mg Injection
Combiflox 1000mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, halting infection spread. Administration must be overseen by a physician. Consistent adherence to the prescribed dosage schedule is crucial; premature cessation can compromise efficacy. Complete the full course of treatment, regardless of symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Seek emergency care for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Disclose all current medications to your doctor before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs. Rest, proper nutrition, and adequate hydration will facilitate recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Burlibact T 1000mg/125mg Injection
Infections caused by bacteria
Major Benefits of Burlibact T 1000mg/125mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strongly discouraged.
Common Side effects of Burlibact T 1000mg/125mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Burlibact T 1000mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Burlibact T 1000mg/125mg Injection works:
Ceftriaxone/Tazobactam (Burlibact T 1000mg/125mg Injection) is a dual-action antibiotic formulation. Ceftriaxone, a cephalosporin, inhibits bacterial cell wall synthesis, thereby disrupting bacterial viability. The beta-lactamase inhibitor, Tazobactam, counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's efficacy.
SAFETY ADVICE
AlcoholSAFE
Burlibact T 1000mg/125mg Injection can be taken with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Burlibact T (1000mg/125mg) is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nonetheless, clinical data in humans are scarce.
Breast feedingCAUTION
The administration of Burlibact T 1000mg/125mg Injection to breastfeeding mothers requires careful consideration. Nursing should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Burlibact T 1000mg/125mg Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Burlibact T 1000mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Exercise caution when administering Burlibact T 1000mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration of Burlibact T 1000mg/125mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Burlibact T 1000mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Burlibact T 1000mg/125mg Injection, seek medical advice.
Facts to Know About Burlibact T 1000mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently